We postulate that low expression of sPD-1 may induce a weak affinity for membranous PD-1 thus allowing benefit to therapeutic anti-PD-1 antibodies to effectively bind and induce an active anti-tumor response. The gene discussed is HOXD13; the disease is neoplasm.